Position in PFE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$91,948,325
+$14,537,338 QoQ
Shares Held
3,274,513
+5.3% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $2,972,093,575 across 11 Drug Manufacturers - General names. PFE ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,409,868 | $1,077,948,133 | |
| 2 | LLY |
ELI LILLY & Co
|
506,081 | $465,478,121 | |
| 3 | ABBV |
AbbVie Inc.
|
2,065,016 | $449,120,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,517,435 | $302,822,256 | |
| 5 | AZN |
Astrazeneca PLC
|
1,444,637 | $284,911,309 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,017,219 | $141,769,812 | |
| 7 | PFE |
Pfizer Inc
This page
|
3,274,513 | $91,948,325 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,465,433 | $88,878,511 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $91,948,325 | 3,274,513 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $77,410,987 | 3,108,875 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $79,157,289 | 3,106,644 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $34,296,473 | 1,414,871 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $21,398,692 | 844,463 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $17,242,191 | 649,913 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $21,603,362 | 746,488 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $24,933,481 | 891,118 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $49,525,314 | 1,784,696 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $49,429,579 | 1,716,901 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $40,746,757 | 1,228,422 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $56,639,348 | 1,544,148 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $56,341,658 | 1,380,923 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $74,148,686 | 1,447,086 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $69,238,691 | 1,582,237 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $81,939,753 | 1,562,841 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $69,238,129 | 1,337,418 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $74,257,205 | 1,257,531 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $58,955,613 | 1,370,742 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $49,560,151 | 1,265,581 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $53,324,473 | 1,471,832 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $35,239,538 | 957,336 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $32,240,082 | 925,915 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $34,328,023 | 1,106,474 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||